Tiefeng Shi

Harbin Medical University — China

Medicine · Health Sciences

8h-index196citations27works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pain Mechanisms and Treatments(5), Thyroid Cancer Diagnosis and Treatment(4), RNA modifications and cancer(4), MicroRNA in disease regulation(3), Neuroscience and Neuropharmacology Research(3)

Publications26 total

Investigating the material basis and molecular mechanisms of Oldenlandia diffusa in the treatment of papillary thyroid carcinoma: a network pharmacology and experimental study
Translational Cancer Research·2026Open Access
METTL3-mediated m6A modification of TACSTD2 mRNA inhibits papillary thyroid cancer progression by activating the TNF signaling and blocking epithelial–mesenchymal transition
Scientific Reports·2025Open Access
APOL1 is a novel prognostic biomarker in thyroid cancer and correlates with immune infiltration
Frontiers in Oncology·2025· 1 citedOpen Access
Identification of specific risk factors and predictive analytics for cardio-cerebral arterial stenosis: a comparative study utilizing framingham risk stratification insights
BMC Neurology·2025· 2 citedOpen Access
Investigating Brain’s Hemodynamic Activities in Response to Single Session of Repetitive Transcranial Magnetic Stimulation Measured by fNIRS
Brain stimulation·2025Open Access
Contrast-enhanced ultrasound combined with percutaneous ultrasound-guide core needle biopsies in the diagnosis of pancreatic lesions: a propensity score-matched study
BMC Cancer·2024Open Access
Investigating the mechanism of METTL16-dependent m6A modification regulating the SAMD11 protein signaling pathway to inhibit thyroid cancer phenotypes
International Journal of Biological Macromolecules·2024· 4 cited
miR-182 Promotes Tumor Growth and Increases Chemoresistance of Human Anaplastic Thyroid Cancer by Targeting Tripartite Motif 8 [Retraction]
OncoTargets and Therapy·2024Open Access
Safety evaluation of station settlement pipeline based on physical-information fusion
Atlantis highlights in engineering/Atlantis Highlights in Engineering·2024Open Access
Ultrasound radiomics models based on multimodal imaging feature fusion of papillary thyroid carcinoma for predicting central lymph node metastasis
Frontiers in Oncology·2023· 9 citedOpen Access
The anti-cancer role of microRNA-143 in papillary thyroid carcinoma by targeting high mobility group AT-hook 2
Bioengineered·2022· 8 citedOpen Access
<p>Phosphoribosyl Pyrophosphate Amidotransferase Promotes the Progression of Thyroid Cancer via Regulating Pyruvate Kinase M2</p>
OncoTargets and Therapy·2020· 18 citedOpen Access
RETRACTED ARTICLE: Long noncoding RNA LINC00520 accelerates progression of papillary thyroid carcinoma by serving as a competing endogenous RNA of microRNA-577 to increase Sphk2 expression
Cell Cycle·2020· 23 citedOpen Access
MiR-let-7e inhibits invasion and magration and regulates HMGB1 expression in papillary thyroid carcinoma
Biomedicine & Pharmacotherapy·2018· 26 citedOpen Access
[Effects of Personality and Psychological Acceptance on Medical Workers' Occupational Stress].
PubMed·2018· 8 cited
miR-182 promotes tumor growth and increases chemoresistance of human anaplastic thyroid cancer by targeting tripartite motif 8
OncoTargets and Therapy·2017· 34 citedOpen Access
Metabotropic Glutamate Receptor 7 (mGluR7) as a Target for Modulating Pain-evoked Activities of Neurons in the Hippocampal CA3 Region of Rats
CNS & Neurological Disorders - Drug Targets·2016· 6 cited
Modulatory role of glutamic acid on the electrical activities of pain-related neurons in the hippocampal CA3 region
Neuroscience Letters·2012· 6 cited
Dopamine Involved in the Nociceptive Modulation in the Parafascicular Nucleus of Morphine-Dependent Rat
Neurochemical Research·2011· 3 cited
Analysis of clinical data of 58 patients with thyroid micro-carcinoma
Harbin Yike Daxue xuebao·2011
page 1 of 2Next →

Frequent Co-authors

Huadong Qin(6), Yao Liu(3), Chunxiao Yang(3), Dongxiao Yang(3), He-Ren Gao(3), Man-Ying Xu(3), Chenlei Shi(2), Yanfei Ma(2), Quan Dai(2), Chen Yang(2), Gary Zhang(2), D. Zhang(2), Runnong Jiao(2), M.-Y. Xu(2), Jiayu Dong(2), Jianting Man(2), Zongyuan Zhang(2), Bing Zhang(1), Chao Ding(1), Hui‐Ming Yu(1)